ABXL
ABXLNYSENONENONE
Key Statistics
Market Cap
—
P/E Ratio
—
EPS
—
Beta
—
52W High
$25.68
52W Low
$22.14
50-Day MA
$25.65
200-Day MA
$25.56
Dividend Yield
9.47%
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About ABXL
Abraxas BioScience (ABXL) is a biopharmaceutical innovator committed to addressing severe medical conditions with significant unmet needs through its robust pipeline of proprietary drug candidates. The company utilizes cutting-edge technologies in drug discovery to develop transformative therapies aimed at improving patient outcomes. With a strong focus on scientific integrity and regulatory adherence, ABXL collaborates with leading academic institutions and industry partners to enhance its research capabilities and accelerate the delivery of effective healthcare solutions.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | 0 |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
1.74%
HV 20-Day
2.69%
HV 30-Day
2.33%
HV 60-Day
3.41%
HV Rank
1.2%
Volatility is currently contracting
More NONE Stocks
SOJESouthern Company (The) Series 2DTGDTE Energy Company 2021 Series EDTBDTE Energy Company 2020 SeriesCGABLThe Carlyle Group Inc. 4.625% Subordinated Notes due 2061MGRBAffiliated Managers Group, Inc.NIQNIQ Global Intelligence plcUZFArray Digital Infrastructure, IUZDArray Digital Infrastructure, IRILYTB. Riley Financial Inc. 6.00% Senior Notes Due 2028HWCPZHancock Whitney Corporation - 6OXLCLOxford Lane Capital Corp. 6.75% Notes due 2031BBBYBed Bath & Beyond, Inc.
Data last updated: 7/9/2026